India News

Gland Pharma to invest ₹400 crore for expanding Hyderabad capacity.

Gland Pharma to invest ₹400 crore for expanding Hyderabad capacity.

Gland Pharma will be investing over ₹400 crore in adding up capabilities to their existing facility in the Genome Valley he to manufacture biologicals, biosimilar, antibodies and recombinant Insulin. The company will recrureit... Full Story

Piramal Alternatives Injects ₹110 Crore into Biodeal Pharmaceuticals

Piramal Alternatives has announced a substantial investment of ₹110 crore in Biodeal Pharmaceuticals Ltd, a prominent contract development and manufacturing... Full Story

Browse All News by Date

"Sadhana Nitro Granted Environmental Clearance for Paracetamol Ingredient Production"

In a significant development, Sadhana Nitro Chem Ltd has obtained environmental regulatory clearance to produce pAP (Para Aminophenol), a crucial... Full Story

More Top Stories

LATEST HEADLINES FROM MIDDLE EAST AND NORTH AFRICA
OUR OTHER PRODUCTS & SERVICES: Projects Database | Tenders Database | About Us | Contact Us | Terms of Use | Advertise with Us | Privacy Policy | Disclaimer | Feedback

This site is best viewed with a resolution of 1024x768 (or higher) and supports Microsoft Internet Explorer 4.0 (or higher)
Copyright © 2016-2024

Technology Partner - Pairscript Software